Home » Topics » BioWorld Science

BioWorld Science
RSS

Hoechst claims RTase inhibitors

March 15, 1996

Glaxo Wellcome, Quidel collaborate on flu management

March 15, 1996

Lidakol clinical trial update

March 15, 1996

Antiviral drugs from Glaxo Wellcome

March 15, 1996

Human lactoferrin produced in transgenic animals

March 15, 1996

UR-9751 dropped from development

March 15, 1996

Antipsoriatic treatment in development at Immune Response

March 15, 1996

Human Genome Sciences claims novel wound-healing agents

March 15, 1996

Zeneca acquires antimigraine drug

March 15, 1996

Abbott and Purdue Pharma to copromote analgesic

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...